Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

 

Publications des scientifiques de l'IRD

Petitdidier Elodie, Pagniez Julie, Pissarra J., Holzmuller P., Papierok G., Vincendeau P., Lemesre Jean-Loup, Bras Goncalves Rachel. (2019). Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis. Npj Vaccines, 4, art. 49 [9 p.].

Fichier PDF disponiblehttp://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers20-01/010077468.pdf[ PDF Link ]

Lien direct chez l'éditeur doi:10.1038/s41541-019-0144-2

Titre
Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis
Année de publication2019
Type de documentArticle référencé dans le Web of Science WOS:000502998700001
AuteursPetitdidier Elodie, Pagniez Julie, Pissarra J., Holzmuller P., Papierok G., Vincendeau P., Lemesre Jean-Loup, Bras Goncalves Rachel.
SourceNpj Vaccines, 2019, 4, p. art. 49 [9 p.]. p. art. 49 [9 p.]
RésuméDogs are the main reservoir of zoonotic visceral leishmaniasis. Vaccination is a promising approach to help control leishmaniasis and to interrupt transmission of the Leishmania parasite. The promastigote surface antigen (PSA) is a highly immunogenic component of Leishmania excretory/secretory products. A vaccine based on three peptides derived from the carboxy-terminal part of Leishmania amazonensis PSA and conserved among Leishmania species, formulated with QA-21 as adjuvant, was tested on naive Beagle dogs in a preclinical trial. Four months after the full course of vaccination, dogs were experimentally infected with Leishmania infantum promastigotes. Immunization of dogs with peptide-based vaccine conferred immunity against experimental infection with L. infantum. Evidence for macrophage nitric oxide production and anti-leishmanial activity associated with IFN-y production by lymphocytes was only found in the vaccinated group. An increase in specific IgG2 antibodies was also measured in vaccinated dogs from 2 months after immunization. Additionally, after challenge with L. infantum, the parasite burden was significantly lower in vaccinated dogs than in the control group. These data strongly suggest that this peptide-based vaccine candidate generated cross-protection against zoonotic leishmaniasis by inducing a Th1-type immune response associated with production of specific IgG2 antibodies. This preclinical trial including a peptide-based vaccine against leishmaniasis clearly demonstrates effective protection in a natural host. This approach deserves further investigation to enhance the immunogenicity of the peptides and to consider the possible engineering of a vaccine targeting several Leishmania species.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052] ; Sciences du monde animal [080] ; Santé : généralités [050]
LocalisationFonds IRD [F B010077468]
Identifiant IRDfdi:010077468
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010077468

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


* PDF Link :

    à télécharger pour citer/partager ce document sur les réseaux sociaux académiques


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito